Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 6/22/23 → 6/22/25 |
Funding
- PPD Investigator Services LLC: $13,491.00
K-321-301 : A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops Aft
- Capoor, Seema (PI)